Výsledky vyhledávání - "Simona Stanková"

Akademický článek

A study of the correlation between phospholipase A2 enzyme activity and anti-complement antibodies in patients with systemic lupus erythematosus

Autor: Ginka Cholakova, Simona Stankova, Alexandra Kapogianni, Maria Gendzhova, Delina Ivanova, Svetla Petrova, Ivanka Tsacheva

Publikováno v: Pharmacia, Vol 71, Iss , Pp 1-6 (2024)

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs or organ systems. SLE and one of its most common complications, lupus nephritis (LN), are characterized by chronic inflammation due to the secretion of pro-infla

Externí odkaz: https://doaj.org/article/73582afbd6bc49ae88ca40e1bee337d8

Zobrazit plný text záznamu

Up-regulated expression of miRNA-29b in patients with Parkinson’s disease on levodopa gel infusion

Autor: Simona Stanková, Zuzana Košutzká, Igor Straka, Andrea Gažová, Michal Minár

Publikováno v: Acta Neurologica Belgica.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89e9946852459e34156b3486ab0b208e
https://doi.org/10.1007/s13760-022-02010-2

Zobrazit plný text záznamu

Neurodevelopmental Gene-Related Dystonia-Parkinsonism with Onset in Adults: A Case with NAA15 Variant

Autor: Igor Straka, Jana Švantnerová, Michal Minár, Simona Stanková, Michael Zech

Publikováno v: Mov. Disord. 37, 1955-1957 (2022)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb15744fa4085c58f7bf42db30ea999f
https://pubmed.ncbi.nlm.nih.gov/36373940

Zobrazit plný text záznamu

Levodopa-Carbidopa Intestinal Gel Improves Symptoms of Orthostatic Hypotension in Patients with Parkinson's Disease-Prospective Pilot Interventional Study

Autor: Simona Stanková, Igor Straka, Zuzana Košutzká, Peter Valkovič, Michal Minár

Publikováno v: Journal of Personalized Medicine; Volume 12; Issue 5; Pages: 718

Parkinson’s disease (PD) is currently considered progressive neurodegeneration of both the central and peripheral nervous systems. Widespread neuropathological changes lead to a complex clinical presentation with typical motor (hypokinesia, tremor,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ac50a1eff6448db421deae07ca899a
https://pubmed.ncbi.nlm.nih.gov/35629141

Zobrazit plný text záznamu

Dyskinesia induced by orphenadrine in fixed combination with diclofenac in two patients with advanced Parkinson's disease

Autor: Jana Švantnerová, Simona Stanková, Peter Matejička, Michal Minár

Publikováno v: Klinická farmakologie a farmacie. 35:99-100

Orfenadrin sa použiva na liecbu parkinsonizmu a muskuloskeletalnych bolestivých syndromov už viac ako 50 rokov. Hlavným dovodom vedľajsich ucinkov tohto lieku je jeho anticholinergický efekt. Uvadzame pripady dvoch pacientok s pokrocilou Parkin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::01ba41187b681771f7d0d11d43f01024
https://doi.org/10.36290/far.2021.016

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání